PIEZO1 and renal cell carcinoma: These findings are consistent with the work of Zhu et al. [30], who conducted a bioinformatics investigation of PIEZO1 mRNA expression in RCC across TCGA, MET500, and CPTAC datasets and found poorer OS in patients with higher PIEZO1 expression.